iRhythm (IRTC) Revenue & Revenue Breakdown
iRhythm Revenue Highlights
Latest Revenue (Y)
$591.84M
Latest Revenue (Q)
$186.69M
Main Segment (Y)
Commercial Payors
iRhythm Revenue by Period
iRhythm Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $591.84M | 20.13% |
| 2023-12-31 | $492.68M | 19.90% |
| 2022-12-31 | $410.92M | 27.29% |
| 2021-12-31 | $322.82M | 21.74% |
| 2020-12-31 | $265.17M | 23.59% |
| 2019-12-31 | $214.55M | 45.66% |
| 2018-12-31 | $147.29M | 49.52% |
| 2017-12-31 | $98.51M | 53.75% |
| 2016-12-31 | $64.07M | 77.29% |
| 2015-12-31 | $36.14M | 66.17% |
| 2014-12-31 | $21.75M | 41.52% |
| 2013-12-31 | $15.37M | - |
iRhythm generated $591.84M in revenue during NA 2024, up 20.13% compared to the previous quarter, and up 275.85% compared to the same period a year ago.
iRhythm Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $186.69M | 17.65% |
| 2025-03-31 | $158.68M | -3.44% |
| 2024-12-31 | $164.32M | 11.38% |
| 2024-09-30 | $147.54M | -0.34% |
| 2024-06-30 | $148.05M | 12.22% |
| 2024-03-31 | $131.93M | -0.44% |
| 2023-12-31 | $132.51M | 6.35% |
| 2023-09-30 | $124.60M | 0.38% |
| 2023-06-30 | $124.13M | 11.39% |
| 2023-03-31 | $111.44M | -1.05% |
| 2022-12-31 | $112.62M | 8.42% |
| 2022-09-30 | $103.88M | 1.79% |
| 2022-06-30 | $102.05M | 10.47% |
| 2022-03-31 | $92.38M | 12.93% |
| 2021-12-31 | $81.80M | -4.25% |
| 2021-09-30 | $85.43M | 5.11% |
| 2021-06-30 | $81.28M | 9.38% |
| 2021-03-31 | $74.31M | -5.71% |
| 2020-12-31 | $78.81M | 9.54% |
| 2020-09-30 | $71.94M | 41.40% |
| 2020-06-30 | $50.88M | -19.92% |
| 2020-03-31 | $63.53M | 7.50% |
| 2019-12-31 | $59.10M | 5.62% |
| 2019-09-30 | $55.96M | 4.92% |
| 2019-06-30 | $53.33M | 12.96% |
| 2019-03-31 | $47.21M | 9.41% |
| 2018-12-31 | $43.16M | 13.26% |
| 2018-09-30 | $38.10M | 7.43% |
| 2018-06-30 | $35.47M | 16.04% |
| 2018-03-31 | $30.57M | 8.46% |
| 2017-12-31 | $28.18M | 12.57% |
| 2017-09-30 | $25.04M | 4.95% |
| 2017-06-30 | $23.85M | 11.27% |
| 2017-03-31 | $21.44M | 14.61% |
| 2016-12-31 | $18.70M | 11.47% |
| 2016-09-30 | $16.78M | 6.65% |
| 2016-06-30 | $15.73M | 22.41% |
| 2016-03-31 | $12.85M | 18.43% |
| 2015-12-31 | $10.85M | 16.16% |
| 2015-09-30 | $9.34M | - |
iRhythm generated $186.69M in revenue during Q2 2025, up 17.65% compared to the previous quarter, and up 141.51% compared to the same period a year ago.
iRhythm Revenue Breakdown
iRhythm Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Centers For Medicare And Medicaid | $142.39M | $122.41M | $103.03M | $44.53M | $72.54M |
| Commercial Payors | $311.61M | $267.19M | $223.98M | $193.87M | $135.94M |
| Non-contracted Third-party Payors | $42.73M | $32.07M | $24.13M | $26.93M | $15.29M |
| Healthcare Institutions | $95.11M | $71.00M | $59.77M | $57.50M | $41.40M |
iRhythm's latest annual revenue breakdown by segment (product or service), as of Dec 24: Commercial Payors (52.65%), Centers For Medicare And Medicaid (24.06%), Healthcare Institutions (16.07%), and Non-contracted Third-party Payors (7.22%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Commercial Payors | $97.72M | $83.80M | $83.32M | $77.26M | $79.25M | $71.77M | $70.63M | $67.34M | $67.32M | $61.91M | $60.77M | $56.02M | $55.45M | $51.75M | $47.70M | $49.94M | $49.63M | $46.59M | $41.37M | $36.32M |
| Non-Contracted Third-Party Payors | $12.66M | $10.09M | $10.81M | $10.30M | $8.80M | $8.20M | $7.72M | $7.26M | $5.72M | $6.17M | $5.49M | $7.35M | $6.55M | $5.28M | $4.61M | - | - | - | - | - |
| Centers For Medicare And Medicaid | $44.48M | $38.11M | $38.34M | $36.01M | $36.25M | $31.79M | $34.05M | $31.01M | $30.87M | $26.49M | $24.76M | $20.06M | $10.95M | $12.41M | $10.99M | $10.18M | $21.52M | $19.98M | - | - |
| Healthcare Institutions | $31.83M | $26.67M | $29.85M | $23.46M | $22.24M | $19.57M | $18.94M | $18.07M | $18.21M | $15.78M | $14.14M | $14.88M | $15.67M | $15.08M | $15.40M | $15.73M | $14.11M | $12.26M | $11.47M | $11.04M |
| Non-contracted Third-party Payors | - | - | - | - | - | - | - | - | - | - | $6.75M | $7.75M | $4.44M | - | - | - | - | - | - | - |
iRhythm's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Commercial Payors (52.34%), Centers For Medicare And Medicaid (23.83%), Healthcare Institutions (17.05%), and Non-Contracted Third-Party Payors (6.78%).
iRhythm Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OSCR | Oscar Health | $9.18B | $2.86B |
| BLCO | Bausch + Lomb | $4.77B | $1.27B |
| BRKR | Bruker | $3.37B | $797.40M |
| TFX | Teleflex | $3.05B | $780.89M |
| RDNT | RadNet | $1.83B | $498.23M |
| IRTC | iRhythm | $591.84M | $186.69M |
| AXSM | Axsome Therapeutics | $385.69M | $150.04M |
| GKOS | Glaukos | $383.48M | $124.12M |
| PCVX | Vaxcyte | - | - |
| NUVL | Nuvalent | - | - |
| MTSR | Metsera | - | - |